The Elsevier Office of Continuing Medical Education and Excerpta Medica would appreciate your opinion, to assist us in the evaluation of the effectiveness of this activity and to identify your ongoing educational needs.

Please complete this evaluation form. You must complete this evaluation form to receive acknowledgement for completing this activity.

PoorFairGoodVery goodExcellent
Recognize that Fabry Disease has two major phenotypes: classic and later-onset
Describe the genotype–phenotype correlations and how these may affect disease progression
Recognize that there is a large variation in disease symptoms in heterozygous females due to random X-chromosomal inactivation
Explain how an individualized approach to patient care is necessary due to genotype, phenotype, and sex
NeverRarelySometimesMost of the timeAlwaysN/A
Implement family-wide screening programs to identify Fabry patients and carriers
Implement newborn screening programs to identify Fabry patients and carriers
Use the mutation to predict phenotype as a treatment guide
Regularly monitor heterozygous females with Fabry disease for signs and symptoms of Fabry disease
Utilize a multidisciplinary approach to maximize supportive care for patients with Fabry disease
NeverRarelySometimesMost of the timeAlwaysN/A
Implement family-wide screening programs to identify Fabry patients and carriers
Implement newborn screening programs to identify Fabry patients and carriers
Use the mutation to predict phenotype as a treatment guide
Regularly monitor heterozygous females with Fabry disease for signs and symptoms of Fabry disease
Utilize a multidisciplinary approach to maximize supportive care for patients with Fabry disease
Strongly disagreeDisagreeNeutralAgreeStrongly agree
Overall, the activity met my learning needs
The information presented was without promotional or commercial bias
The content provided a fair and balanced coverage of the topic
The content was scientifically rigorous and evidence-based
The event provided appropriate and effective opportunities for active learning (e.g. discussion, Q&A)
The quality of the educational process was satisfactory and appropriate
The event promoted improvements or quality in health care
The information provided with regard to faculty financial relationships met my needs for disclosure
The speakers were knowledgeable and presented the information clearly
The format of the discussion was relevant and enhanced my knowledge of the subject
PoorFairGoodVery goodExcellent
Robert J. Desnick, MD, PhD
Robert J. Hopkin, MD
Dominique P. Germain, MD, PhD

Attestation to time spent on activity:

The Elsevier Office of Continuing Medical Education designates this live activity for a maxiumum of 1.5 AMA PRA Category 1 CreditTM.